Showing results (101-110 of 115) with videos related to
Sort By:
Pageof 12
Journal of Neuroimmunology|July 30, 2013
Apotransferrin inhibits interleukin-2 expression and protects mice from experimental autoimmune encephalomyelitisTamara Saksida, Djordje Miljkovic, Gordana Timotijevic, et al.Journal of Inflammation (London, England)|November 2, 2010
HE3286, an oral synthetic steroid, treats lung inflammation in mice without immune suppressionDouglas Conrad, Angela Wang, Raymond Pieters, et al.European Journal of Pharmacology|March 5, 2011
HE3286, an orally bioavailable synthetic analogue of an active DHEA metabolite suppresses spontaneous autoimmune diabetes in the non-obese diabetic (NOD) mouseMichele M Kosiewicz, Dominick L Auci, Paolo Fagone, et al.Oncology Reports|April 6, 2006
Analysis of interleukin (IL)-1beta IL-1 receptor antagonist, soluble IL-1 receptor type II and IL-1 accessory protein in HCV-associated lymphoproliferative disordersMassimo Libra, Katia Mangano, Massimiliano Anzaldi, et al.International Journal of Molecular Medicine|July 3, 2015
Identification of novel targets for the diagnosis and treatment of liver fibrosisPaolo Fagone, Katia Mangano, Santa Mammana, et al.Journal of Cellular Physiology|April 21, 2011
Cytotoxic and immune-sensitizing properties of nitric oxide-modified Saquinavir in iNOS-positive human melanoma cellsSanja Mijatovic, Danijela Maksimovic-Ivanic, Marija Mojic, et al.The Journal of Pharmacology and Experimental Therapeutics|December 7, 2006
A potent immunomodulatory compound, (S,R)-3-Phenyl-4,5-dihydro-5-isoxazole acetic acid, prevents spontaneous and accelerated forms of autoimmune diabetes in NOD mice and inhibits the immunoinflammatory diabetes induced by multiple low doses of streptozotocin in CBA/H miceStanislava Stosic-Grujicic, Ivana Cvetkovic, Katia Mangano, et al.Molecular Cancer Therapeutics|March 19, 2008
Anticancer properties of the novel nitric oxide-donating compound (S,R)-3-phenyl-4,5-dihydro-5-isoxazole acetic acid-nitric oxide in vitro and in vivoDanijela Maksimovic-Ivanic, Sanja Mijatovic, Ljubica Harhaji, et al.International Journal of Molecular Sciences|November 25, 2020
Immune-Modulating Drug MP1032 with SARS-CoV-2 Antiviral Activity In Vitro: A potential Multi-Target Approach for Prevention and Early Intervention Treatment of COVID-19Sara Schumann, Astrid Kaiser, Ferdinando Nicoletti, et al.Cell Cycle (Georgetown, Tex.)|February 29, 2012
Saquinavir-NO-targeted S6 protein mediates sensitivity of androgen-dependent prostate cancer cells to TRAILMarija Mojic, Sanja Mijatovic, Danijela Maksimovic-Ivanic, et al.Pageof 12